Japanese startup Alpha Fusion accelerates astatine-based drug discovery with Series B funding

Alpha Fusion, Inc., working on research outcomes from Osaka University and the Japan Science and Technolo...

October 13, 2024 | Sunday | News
Japan's Astellas and UK-based AviadoBio ink billion dollar deal for gene therapy targeting frontotemporal dementia

UK-based AviadoBio and Japan's Astellas Pharma Inc. have announced an exclusive option and license agreement for AVB-101...

October 10, 2024 | Thursday | News
Lifebit and Flatiron Health advances cancer care in Japan through real-world data

Flatiron Health and Lifebit Biotech are expanding their collaboration into Japan to transform cancer care, facilitating ...

October 9, 2024 | Wednesday | News
Japanese startup Rege Nephro raises ¥ 22.5 B to accelerate kidney disease therapy trials

Japan-based startup Rege Nephro Co. has successfully developed a funding plan of total 25 billion yen (¥) in new Ser...

October 8, 2024 | Tuesday | News
Curium inks strategic partnership with PeptiDream for prostate cancer theranostics in Japan

Paris-based Curium, a world leader in nuclear medicine, has entered into a strategic partnership with PDRadiopharma Inc,...

October 3, 2024 | Thursday | News
Terumo Asia Holdings unveils Terumo Asia Skill Lab with the expansion of Singapore office

Japan's TERUMO Asia Holdings has launched its “Terumo Asia Skill Lab” at its Asia-Pa...

October 2, 2024 | Wednesday | News
Japanese medtech firm Olympus introduces new imaging platform VISERA S

Olympus Corporation, a global medtech company headquartered in Japan, has announced the launch of VISERA S, the all-in-o...

October 1, 2024 | Tuesday | News
Japan approves Boston Scientific's FARAPULSE Pulsed Field Ablation System

US-based Boston Scientific Corporation has received Pharmaceuticals and Medical Device Agency (PMDA) approval in&nb...

September 29, 2024 | Sunday | News
Nxera Pharma receives approval of insomnia drug in Japan

Nxera Pharma, formerly known as Sosei Group or Sosei Heptares, has received approval from the Ministry of Health, Labour...

September 24, 2024 | Tuesday | News
Japan’s Takeda Pharma provides over $32 M for five new global CSR partnerships

Japanese pharma firm Takeda has awarded JPY 4.6 billion (approximately $32 million) to five new partners in the field of...

September 20, 2024 | Friday | News
Japan-based analytical instrument firm Shimadzu begins operations in Mexico

Japan's Shimadzu Corporation has established a subsidiary in Mexico and has begun its activities. To date, in Mexico, an...

September 18, 2024 | Wednesday | News
Japan approves iRhythm Technologies' AI-based ECG monitoring system

US-based iRhythm Technologies, Inc., a leading digital healthcare company focused on creating trusted solutions that det...

September 17, 2024 | Tuesday | News
Japan approves self-amplifying mRNA COVID-19 vaccine for protection against JN.1 strain

Global biotechnology leader CSL and self amplifying-mRNA pioneer Arcturus Therapeutics have announced that Japan's Minis...

September 13, 2024 | Friday | News
French firm Osivax grants rights to KM Biologics to develop and market influenza vaccine in Japan

Osivax, a FRance-based biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly...

September 10, 2024 | Tuesday | News
Antibody Engineering & Therapeutics Asia 2024: A Premier Gathering for Cutting-Edge Antibody Research and Innovation

Antibody Engineering & Therapeutics Asia: Date: October 21 – 23, 2024Location: The Westin Miyako Kyoto Antib...

September 1, 2024 | Sunday | News
Japan-based Takara Bio launches large-scale qPCR system to advance broad surveillance of antimicrobial resistance

Takara Bio USA, Inc., a wholly owned subsidiary of Japan-based Takara Bio Inc., has announced the launch of the SmartChi...

September 6, 2024 | Friday | News
US-based Rigel inks $162.5 M oncology deal with Kissei for Japan, Korea and Taiwan markets

US-based Rigel Pharmaceuticals, Inc., a commercial stage biotechnology company focused on hematologic disorders and canc...

September 5, 2024 | Thursday | News
Japan's Rigaku Corp develops solution to accelerate biopharmaceutical R&D

Rigaku Corporation, a Rigaku Holdings Group company and global partner for X-ray analysis from Lab to Fab in Japan, has ...

September 4, 2024 | Wednesday | News